Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer - Wikidata - awgldk - TriplyDB

Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer

Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer

http://www.wikidata.org/entity/Q34575227

about

FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers: a meta analysis Impact Of Circulating T Helper 1 And 17 Cells in the Blood on Regional Lymph Node Invasion in Colorectal Cancer Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival.Presence of FOXP3(+)Treg cells is correlated with colorectal cancer progression Expression and DNA methylation of TNF, IFNG and FOXP3 in colorectal cancer and their prognostic significance.Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives.Foxp3-dependent transformation of human primary CD4+ T lymphocytes by the retroviral protein tax CD4⁺ follicular helper T cell infiltration predicts breast cancer survival Negative immune factors might predominate local tumor immune status and promote carcinogenesis in cervical carcinoma.Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era.Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer Hydroquinone-induced FOXP3-ADAM17-Lyn-Akt-p21 signaling axis promotes malignant progression of human leukemia U937 cells.FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway.A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).Foxp3 is correlated with VEGF-C expression and lymphangiogenesis in cervical cancer.The role of FOXP3 in disease progression in colorectal cancer patients Convergences and divergences of thymus- and peripherally derived regulatory T cells in cancer The appearance of Tregs in cancer nest is a promising independent risk factor in colon cancer.Tumor-infiltrating FoxP3+ Tregs predict favorable outcome in colorectal cancer patients: A meta-analysis.The Clinicopathological and Prognostic Implications of FoxP3+ Regulatory T Cells in Patients with Colorectal Cancer: A Meta-Analysis.Effects of exogenous IL-37 on the biological characteristics of human lung adenocarcinoma A549 cells and the chemotaxis of regulatory T cells.Upregulation of Treg-Related Genes in Addition with IL6 Showed the Significant Role for the Distant Metastasis in Colorectal Cancer.Foxp3 expression in CD4+CD25+Foxp3+ regulatory T cells promotes development of colorectal cancer by inhibiting tumor immunity.Expression of Foxp3 and its prognostic significance in colorectal cancer.FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma.Immunohistochemical Analysis of Foxp3+, CD4+, CD8+ Cell Infiltrates and PD-L1 in Oral Squamous Cell Carcinoma.

P2860

Q24567994-0B896534-CFA9-4FAD-8528-676C5411425A Q27024810-186A1498-BEA4-47C6-A988-4075739AF43E Q33567742-83A176F2-42F0-4D8B-868C-6317E344658E Q33609920-E68C568B-61A4-43E2-924B-A66AA3E854A3 Q33776744-25E89101-4FA4-495D-B8D1-B9E162CE9388 Q33818673-4AD45856-A8CD-4956-BD42-A6DCB799FBA2 Q34042234-5A4EE207-7845-4221-8693-C5AAAD700C1E Q34354653-5636CE17-B1AA-47A5-B461-E2E9E81B44A0 Q34708248-BB321461-0DCB-47E4-9BEC-52B7C66E1A62 Q36114649-CBB3B0EB-8049-41AC-BAB9-E96A5D0DE249 Q36198214-E92689C1-5431-4713-A0AF-09D381102058 Q36966923-2E995F53-DDFE-4059-B117-AC6CA194F23A Q37586829-96580554-578E-4672-856F-A6E0E0873C79 Q37697529-E45BCCC2-53F1-40BB-A8BD-6BA2A2B5053F Q38241953-EA25EFDF-B366-400F-BFE1-0DF671DBDB25 Q38876048-F9CD98A3-8E61-496A-9680-DD9603E6EA50 Q39680352-DAA38ED0-7043-401A-8997-CCD12C1CFFC8 Q40042902-38E4218C-F99A-4068-AD8A-A84A6119813A Q41126888-5578A4CA-61BF-4ED9-BEB3-F639B43B1E7E Q41718955-3CA90176-6C10-4E1C-86AB-6B24D385498D Q41979638-B1752FFB-82AA-498E-9D7E-52BB3FA5F2A1 Q42571627-0E30105F-7E76-4F70-94AA-160279B3E158 Q44646853-67637106-3986-4C37-B96A-C2A977E7BACF Q46479553-7545AF91-E427-422B-BB7B-E9A895174D69 Q47101966-39C15FB7-BADF-4859-8950-5EF73D0124EE Q47253631-35D89E5D-7152-4C6C-919E-F32173FCFFDF Q49175582-5194B151-F8B5-4EE9-9393-4D438086F52D Q51382004-C893A9F2-28DE-490F-A987-CFBD5AE6BD1A Q52863986-49C39914-5297-42A9-9E11-E00A07396642 Q55001270-35011F91-51B2-436F-AFA0-EC0A733AD736 Q55180399-EFBBE3B6-A9B0-4F5F-A529-18A0F1119BFB

P2860

Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer

http://www.wikidata.org/entity/Q34575227

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Expression of Foxp3 in colorec ...... atients with colorectal cancer

@ast

Expression of Foxp3 in colorec ...... atients with colorectal cancer

@en

Expression of Foxp3 in colorec ...... atients with colorectal cancer

@nl

type

label

Expression of Foxp3 in colorec ...... atients with colorectal cancer

@ast

Expression of Foxp3 in colorec ...... atients with colorectal cancer

@en

Expression of Foxp3 in colorec ...... atients with colorectal cancer

@nl

prefLabel

Expression of Foxp3 in colorec ...... atients with colorectal cancer

@ast

Expression of Foxp3 in colorec ...... atients with colorectal cancer

@en

Expression of Foxp3 in colorec ...... atients with colorectal cancer

@nl

P1433

Q34575227-6B68B479-AD32-4010-B5CC-8CF57FD96680

P1476

Q34575227-3B4C624D-FF33-4365-BAE8-2652A857C968

P2093

Q34575227-2F1669EC-0AC0-49AE-8E8C-AC9F040846D8

Q34575227-31872C94-77F4-4B77-807E-24D10FC1C0B7

Q34575227-4FD2F830-8857-4163-ACDD-E6223662E6B4

Q34575227-6CBA2194-D905-4AD8-BCD4-362887E72E38

Q34575227-73E83A95-A881-4F96-A4CF-6B7655D5E83B

Q34575227-75C7FE6E-AD02-4D51-B59E-CF3B72B02B2A

Q34575227-76F1348F-8C9F-40F5-94F8-61BDD68C2A45

Q34575227-AC58A673-3D69-4532-B5F5-BD7B6B50A207

Q34575227-B2985CE0-43B5-43AB-92AE-F9492FF04D77

Q34575227-EA8397B6-F2AC-41E3-8F98-4A48C8812E3D

P2860

Q34575227-0FB7B995-C379-47EE-B61F-B7DBC38F1ECD

Q34575227-42356CA5-110C-480D-A92D-B791D4CAFA56

Q34575227-4335F18B-A4AA-41DF-AD33-319A9F81E793

Q34575227-4543A90F-0FA9-4647-8E80-7E40FAA015A2

Q34575227-593AC917-89A2-45C1-864F-14A389B89660

Q34575227-64540CFF-2030-451E-B764-0B3A6EE388E4

Q34575227-66282CE7-2B42-49C3-A04E-B2A3DC45041D

Q34575227-6ED4B301-5B75-42EC-9A37-105058A3A7D2

Q34575227-6FD7235D-E18D-4CF9-AED2-5BC73795FF62

Q34575227-75437DC9-980A-4F0A-B882-9674192CFAD6

P304

Q34575227-34F3B465-95B7-4358-8C54-1D4C79F0053E

P31

Q34575227-A3B3B8BB-4EAF-4B71-973C-0DC76E612B8C

P356

Q34575227-2F2D8BCD-428F-4BAC-817F-4EC3CCFBCA65

P407

Q34575227-79BCA87A-4E38-41F0-AE6F-E18F22659BAF

P433

Q34575227-C1FB847B-2C42-411C-BAD5-F808ADDEEBF2

P478

Q34575227-66AB6098-AA99-45C1-A7C3-E367B5CAD7D6

P577

Q34575227-C157364E-C27D-498E-BD8C-BF73BE01B9D7

P5875

Q34575227-F1C690FC-FAAD-4086-85D7-2BDDA28ACC52

P698

Q34575227-734B173D-3A06-4C44-8AF7-BAE5600DF4E2

P921

Q34575227-F275737A-C8CD-4A3A-B768-3C3539F22021

Q34575227-F78DB3E3-CE24-41BA-B160-9D43F05687C2

P932

Q34575227-1E4AB3EC-9D3D-4811-B8B7-F12E036DB9B0

P356

JOURNAL.PONE.0053630

P1433

P1476

Expression of Foxp3 in colorec ...... atients with colorectal cancer

@en

P2093

Ana Maria Waaga-Gasser

http://www.w3.org/2001/XMLSchema#string

Andreas Rosenwald

http://www.w3.org/2001/XMLSchema#string

Christoph-Thomas Germer

http://www.w3.org/2001/XMLSchema#string

Eva Meier

http://www.w3.org/2001/XMLSchema#string

Igor Tsaur

http://www.w3.org/2001/XMLSchema#string

Maria Lazariotou

http://www.w3.org/2001/XMLSchema#string

Martin Gasser

http://www.w3.org/2001/XMLSchema#string

Martin Grimm

http://www.w3.org/2001/XMLSchema#string

Mia Kim

http://www.w3.org/2001/XMLSchema#string

Roman Blaheta

http://www.w3.org/2001/XMLSchema#string

P2860

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Validation of an appropriate reference gene for normalization of reverse transcription-quantitative polymerase chain reaction data from rectal cancer biopsies.

Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

FOXP3 expression and clinical characteristics of hepatocellular carcinoma

Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

Inflammation, a key event in cancer development.

TNM staging for malignancies of the digestive tract: 2003 changes and beyond.

P304

e53630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0053630

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235402765

http://www.w3.org/2001/XMLSchema#string

P698

23382847

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3559740

http://www.w3.org/2001/XMLSchema#string